Company / Operating Income per Share
Amylyx Pharmaceuticals, Inc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.40
FY2025
5-year range
-$28.68 / $0.57
FY2021-FY2025
Trend
+69.6%
vs FY2024
Sector context
#99 of 201
Health Care
What the data says
At $-1.40, Amylyx Pharmaceuticals, Inc.'s operating income per share ranks #99 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 5 years, ranging from $-28.68 in FY2022 to $0.57 in FY2023.
Based on SEC 10-K filings.
-1.40 in FY2025.
Declined from $0.57 to $-1.40 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#99 of 201 in Health CareTop 49% of 201This company -$1.40 Sector average -$28.56
▼
+95.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 69.6% year-over-year.
- Ranks #99 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.40 | +69.6% |
| FY2024 | -$4.59 | -900.2% |
| FY2023 | $0.57 | +102.0% |
| FY2022 | -$28.68 | -128.4% |
| FY2021 | -$12.55 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026